Cargando…

A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy

To determine the incidence, spectrum, timing, and clinical features of CD19 Chimeric antigen receptor (CAR-T) cell therapy-associated fatal toxic effects. We initiated a comprehensive analysis. First, we retrospectively queried the real-world data from a World Health Organization (WHO) pharmacovigil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Changjing, Tang, Diya, Han, Ying, Shen, Edward, Abdihamid, Omar, Guo, Cao, Shen, Hong, Zeng, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585129/ https://www.ncbi.nlm.nih.gov/pubmed/32973124 http://dx.doi.org/10.18632/aging.104058

Ejemplares similares

Which cancer type has the highest risk of COVID-19 infection?
por: Cai, Changjing, et al.
Publicado: (2020)

The Landscape of COVID-19 in Cancer Patients: Prevalence, Impacts, and Recommendations
por: Abdihamid, Omar, et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Rugambwa, Tibera K., et al.
Publicado: (2023)

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
por: Cai, Changjing, et al.
Publicado: (2021)

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)

Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality
por: Cai, Changjing, et al.
Publicado: (2021)

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients
por: Shen, Edward, et al.
Publicado: (2021)

The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma
por: Deng, Ganlu, et al.
Publicado: (2017)

ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells
por: Guo, Cao, et al.
Publicado: (2017)

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020)

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling
por: Han, Ying, et al.
Publicado: (2020)

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer
por: Cai, Changjing, et al.
Publicado: (2021)

BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation
por: Deng, Ganlu, et al.
Publicado: (2018)

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma
por: He, Min, et al.
Publicado: (2021)

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells
por: Karschnia, Philipp, et al.
Publicado: (2021)

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner
por: Han, Ying, et al.
Publicado: (2022)

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma
por: Huang, Qiaoqiao, et al.
Publicado: (2022)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

Extracellular Vesicles Promote the Formation of Pre-Metastasis Niche in Gastric Cancer
por: Tang, Diya, et al.
Publicado: (2022)

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model
por: Cai, Changjing, et al.
Publicado: (2022)

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Fu, Wenyan, et al.
Publicado: (2019)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
por: Jess, Jennifer, et al.
Publicado: (2023)

Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myeloma
por: Li, Hujun, et al.
Publicado: (2022)

Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy
por: Eder, Lea Naomi, et al.
Publicado: (2023)

Complexities in comparing the impact of costimulatory domains on approved CD19 CAR functionality
por: Smith, Richard, et al.
Publicado: (2023)

Patient-derived xenograft models in cancer therapy: technologies and applications
por: Liu, Yihan, et al.
Publicado: (2023)

Rare metastasis of nasopharyngeal carcinoma to the thyroid gland with subsequent metastatic abdominal lymph nodes: A case report and literature review
por: Cai, Changjing, et al.
Publicado: (2017)

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers
por: Chen, Yihong, et al.
Publicado: (2023)

CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
por: Bueno, Clara, et al.
Publicado: (2019)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

Colchicine Toxicity: The Fatal Masquerader
por: Mulkareddy, Vinaya, et al.
Publicado: (2020)

RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning
por: Ferrey, Anne E., et al.
Publicado: (2018)

Drug Use among Iranian Drivers Involved in Fatal Car Accidents
por: Assari, Shervin, et al.
Publicado: (2014)

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
por: Li, Wenjie, et al.
Publicado: (2023)

A Fatal Case of Febrile Ulceronecrotic Mucha-Habermann Disease which Presenting as Toxic Epidermal Necrolysis
por: Xing, Chenjing, et al.
Publicado: (2017)

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
por: Cao, Xuanqi, et al.
Publicado: (2022)

CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity
por: Shi, Jiangzhou, et al.
Publicado: (2021)

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy
por: Juluri, Krishna R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cl9snce3ij48jvp7msf8eeo7f1